Abdallah G Kfoury

Summary

Affiliation: LDS Hospital
Country: USA

Publications

  1. doi request reprint Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients
    Abdallah G Kfoury
    Heart Failure Prevention and Treatment Program, Intermountain Medical Center and Intermountain Healthcare, 5121 S Cottonwood Street, Murray, UT 84107, USA
    J Card Fail 14:95-102. 2008
  2. ncbi request reprint Early screening for antibody-mediated rejection in heart transplant recipients
    Abdallah G Kfoury
    LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1264-9. 2007
  3. doi request reprint Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection
    Monica P Revelo
    Utah Transplantation Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, UT, USA
    Cardiovasc Pathol 21:445-54. 2012
  4. doi request reprint A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Utah, USA
    J Heart Lung Transplant 28:51-7. 2009
  5. doi request reprint Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant
    Melanie D Everitt
    Division of Cardiology, University of Utah, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:686-93. 2012
  6. doi request reprint Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
    Monica P Revelo
    George E Wahlen Veterans Affairs Medical Center, Utah Transplantation Affiliated Hospitals, Salt Lake City, Utah, USA
    J Heart Lung Transplant 30:144-50. 2011
  7. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
  8. doi request reprint Exceptional mortality prediction by risk scores from common laboratory tests
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, Murray, Utah 84157, USA
    Am J Med 122:550-8. 2009
  9. doi request reprint The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, 5121 S Cottonwood St, Salt Lake City, UT 84107, USA
    Eur J Heart Fail 12:1203-13. 2010
  10. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012

Collaborators

Detail Information

Publications55

  1. doi request reprint Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients
    Abdallah G Kfoury
    Heart Failure Prevention and Treatment Program, Intermountain Medical Center and Intermountain Healthcare, 5121 S Cottonwood Street, Murray, UT 84107, USA
    J Card Fail 14:95-102. 2008
    ..Although adherence to these HF care processes may be improving, their collective impact on survival is not yet settled...
  2. ncbi request reprint Early screening for antibody-mediated rejection in heart transplant recipients
    Abdallah G Kfoury
    LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1264-9. 2007
    ..In this study, we examine whether a pattern of repetitive AMR occurred early enough after transplantation to warrant prospective immunohistochemistry screening in all recently transplanted recipients...
  3. doi request reprint Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection
    Monica P Revelo
    Utah Transplantation Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, UT, USA
    Cardiovasc Pathol 21:445-54. 2012
    ..The tissue level mechanisms leading to graft failure in some patients with antibody-mediated rejection are poorly characterized...
  4. doi request reprint A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Utah, USA
    J Heart Lung Transplant 28:51-7. 2009
    ..In this study, we hypothesized that the severity of AMR, as assessed on EMBs, correlates with cardiovascular mortality in heart transplant recipients...
  5. doi request reprint Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant
    Melanie D Everitt
    Division of Cardiology, University of Utah, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:686-93. 2012
    ..Yet, compared with adults, the lack of routine surveillance for AMR has limited the growth of evidence in the pediatric population. Herein, we compared outcomes of pediatric HT recipients with and without AMR...
  6. doi request reprint Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
    Monica P Revelo
    George E Wahlen Veterans Affairs Medical Center, Utah Transplantation Affiliated Hospitals, Salt Lake City, Utah, USA
    J Heart Lung Transplant 30:144-50. 2011
    ....
  7. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
    ..Survival of patients on left ventricular assist devices (LVADs) has improved. We examined the differences in risk of adverse outcomes between LVAD-supported and medically managed candidates on the heart transplant waiting list...
  8. doi request reprint Exceptional mortality prediction by risk scores from common laboratory tests
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, Murray, Utah 84157, USA
    Am J Med 122:550-8. 2009
    ..Many of their components are not commonly used, but they might contain independent risk information. This study tested the ability of a risk score combining all components to predict all-cause mortality...
  9. doi request reprint The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, 5121 S Cottonwood St, Salt Lake City, UT 84107, USA
    Eur J Heart Fail 12:1203-13. 2010
    ..Mortality is the most definitive clinical endpoint, but medical care is more easily applied to modify morbidity and thereby prevent death. This study tested whether IMRS is associated with clinical morbidity endpoints...
  10. doi request reprint A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    J Heart Lung Transplant 31:46-51. 2012
    ..Debate continues about whether therapeutic intervention is warranted to avoid adverse outcomes. In this study we examine the course of individual episodes of untreated asymptomatic AMR on follow-up endomyocardial biopsy (EMB)...
  11. ncbi request reprint Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals U T A H Cardiac Transplant Program, LDS Hospital, and University of Utah School of Medicine, Salt Lake City, Utah 84143, United States
    Eur J Heart Fail 9:845-9. 2007
    ....
  12. doi request reprint Superior predictive ability for death of a basic metabolic profile risk score
    Heidi T May
    Intermountain Medical Center, Murray, UT 84157, USA
    Am Heart J 157:946-54. 2009
    ..Although individual variables are checked for cardiovascular health and risk, combining them into a total BMP-derived score, as to maximize BMP predictive ability, has not been previously attempted...
  13. ncbi request reprint Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease
    Heidi T May
    LDS Hospital, Salt Lake City, Utah 84143, USA
    Cardiology 107:178-84. 2007
    ..Whether HCY affects development of congestive heart failure (CHF) independent of coronary artery disease (CAD) is uncertain. We evaluated whether increased HCY predicts low ejection fraction or clinical CHF...
  14. doi request reprint Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function
    Feras M Bader
    Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Congest Heart Fail 15:63-7. 2009
    ..BNP levels do predict allograft rejection but correlate with allograft function after 6 months following transplant...
  15. doi request reprint Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
    J Heart Lung Transplant 28:781-4. 2009
    ..In this study, we examined whether a differential impact on cardiovascular mortality (CVM) existed when comparing asymptomatic AMR, to stable MR or CR...
  16. doi request reprint Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation
    Jose N Nativi
    Department of Medicine, Division of Cardiology, University of Utah, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 30:854-61. 2011
    ..Our aim was to determine the impact of the type of LVAD and implant era on post-transplant survival...
  17. ncbi request reprint Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients
    Stavros G Drakos
    LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA
    Ann Thorac Surg 82:889-93. 2006
    ....
  18. doi request reprint The intermountain risk score predicts incremental age-specific long-term survival and life expectancy
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah, USA
    Transl Res 158:307-14. 2011
    ..IMRS may be used to stratify age-specific risk of mortality in research, clinical/preventive, and quality improvement applications. A web calculator is located at http://intermountainhealthcare.org/IMRS...
  19. ncbi request reprint Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Thorac Cardiovasc Surg 133:1612-9. 2007
    ..We investigated the pattern of sensitization in left ventricular assist device recipients in relation to cellular blood product transfusions received...
  20. doi request reprint Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II
    Omar Wever-Pinzon
    Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City, UT, USA
    Circ Heart Fail 6:517-26. 2013
    ..Reduced pulsatility has been implicated as a contributing cause. The aim of this study was to assess the effects of different degrees of pulsatility on the incidence of nonsurgical bleeding...
  21. doi request reprint Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Divisions of Cardiology and Cardiothoracic Surgery, University of Utah Health Sciences Center, Intermountain Medical Center, Salt Lake City, Utah 84132, USA
    J Am Coll Cardiol 61:1985-94. 2013
    ..This study sought to prospectively investigate the longitudinal effects of continuous-flow left ventricular assist device (LVAD) unloading on myocardial structure and systolic and diastolic function...
  22. doi request reprint Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation
    Jennifer L Nixon
    Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
    Clin Transplant 26:322-7. 2012
    ..Our study evaluated whether the use of high-dose inotropic support in potential donors was associated with increased early myocardial necrosis (MN) and worse clinical outcomes after cardiac transplantation...
  23. doi request reprint Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices
    Pere A Ventura
    Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, UT, USA
    Clin Transplant 25:E390-5. 2011
    ..In this study, we compared the post-transplant (PTx) outcomes between XVE and HMII using a large national data registry...
  24. doi request reprint Risk factors predictive of right ventricular failure after left ventricular assist device implantation
    Stavros G Drakos
    Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah University of Utah School of Medicine, Salt Lake City, Utah, USA
    Am J Cardiol 105:1030-5. 2010
    ....
  25. pmc Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization
    Stavros G Drakos
    Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, UT 84112, USA
    J Heart Lung Transplant 28:838-42. 2009
    ..04). Pre-sensitized patients are at higher risk for becoming and remaining highly HLA-allosensitized after LVAD implantation. The HeartMate II LVAD appears to cause less sensitization than HeartMate I...
  26. ncbi request reprint Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies
    M Elizabeth H Hammond
    Department of Pathology, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 24:2015-21. 2005
    ..The aim of this study was to determine whether VASC and ENDO are adequate to act as screening parameters to trigger further AMR investigation...
  27. ncbi request reprint Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns
    Abdallah G Kfoury
    LDS Hospital, Intermountain Health Care, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 25:1277-82. 2006
    ..The current retrospective analysis was done to determine whether our previous criteria for pattern designations provided the greatest degree of discrimination between AMR and CR...
  28. ncbi request reprint Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide
    Heidi T May
    LDS Hospital, Intermountain Medical Center, Salt Lake City, Utah, USA
    Am J Cardiol 100:697-700. 2007
    ..02). In conclusion, the SHFM predicts survival in patients with HF in a hospital-based population, with areas under the curve similar to those from data on which models were initially fit...
  29. doi request reprint Allograft rejection in patients supported with continuous-flow left ventricular assist devices
    Aaron H Healy
    UTAH Utah Transplant Affiliated Hospitals Cardiac Transplant Program, University of Utah, Salt Lake City, Utah 84132, USA
    Ann Thorac Surg 92:1601-7; discussion 1607. 2011
    ..We sought to analyze the relationship between LVAD flow characteristics and subsequent allograft rejection in bridge to transplant (BTT) patients...
  30. pmc Repeated measurement of the intermountain risk score enhances prognostication for mortality
    Benjamin D Horne
    Intermountain Heart Institute, Intermountain Medical Center, Salt Lake City, Utah, USA
    PLoS ONE 8:e69160. 2013
    ..Whether longitudinal repeated measurement of IMRS is useful for prognostication is an important question for its clinical applicability...
  31. doi request reprint Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS)
    Melanie D Everitt
    University of Utah, and Division of Pediatric Cardiology, Primary Children s Medical Center, 100 Mario Capecchi Drive, Salt Lake City, UT 84113, USA
    J Heart Lung Transplant 30:395-401. 2011
    ..HF management and approach to orthotopic heart transplant (OHT) may differ from adults without CHD. We sought to compare OHT waitlist characteristics and outcomes for these 2 groups...
  32. doi request reprint Outcome of noncardiac surgery in patients with ventricular assist devices
    Josef Stehlik
    VA Salt Lake City Health Care System, Cardiology Division, Salt Lake City, Utah, USA
    Am J Cardiol 103:709-12. 2009
    ..In conclusion, outcomes after noncardiac surgery in patients with VADs are favorable, and most patients continue to benefit from the intended purpose of mechanical circulatory support after recovering from noncardiac surgery...
  33. pmc Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart
    Stavros G Drakos
    Cardiovascular Department and Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, Utah, USA
    J Am Coll Cardiol 56:382-91. 2010
    ..This study investigates alterations in myocardial microvasculature, fibrosis, and hypertrophy before and after mechanical unloading of the failing human heart...
  34. doi request reprint Temporal trends in heart transplantation from high-risk donors: are there lessons to be learned? A multi-institutional analysis
    Jose N Nativi
    Department of Cardiology, University of Utah Health Science Center, U T A H Cardiac Transplant Program, Salt Lake City, UT 84132, USA
    J Heart Lung Transplant 29:847-52. 2010
    ..After the ODBC, increases in the number of all solid organs transplanted, except for heart, were seen. The aim of this study was to determine if ODBC resulted in temporal changes in the use of hearts from high-risk donors...
  35. ncbi request reprint Effect of reversible pulmonary hypertension on outcomes after heart transplantation
    Stavros G Drakos
    Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:319-23. 2007
    ..Conflicting data exist regarding the impact of reversible pulmonary hypertension (PHTN) on post-transplant (Tx) outcomes. In this study we sought to determine the influence of reversible PHTN on outcomes after Tx...
  36. doi request reprint Utility of virtual crossmatch in sensitized patients awaiting heart transplantation
    Josef Stehlik
    U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
    J Heart Lung Transplant 28:1129-34. 2009
    ..This study examined the accuracy of virtual crossmatch, in which recipient HLA-specific antibodies, identified by solid-phase assays, are compared to the prospective donor HLA-type in heart transplantation...
  37. doi request reprint Obesity and left ventricular assist device driveline exit site infection
    Ashley L Raymond
    Utah Artificial Heart Program, Intermountain Medical Center, Murray, Utah, USA
    ASAIO J 56:57-60. 2010
    ..These results may warrant increased measures to prevent and treat infection in the preimplant and postimplant periods...
  38. pmc Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography
    Benjamin D Horne
    Cardiovascular Department, Intermountain Medical Center, Murray, Utah, USA
    Am J Cardiol 102:814-819. 2008
    ..In conclusion, not only proscription of tobacco, but also routine periodic fasting was associated with lower risk of CAD...
  39. pmc Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action
    Stavros G Drakos
    UTAH Cardiac Transplant Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Curr Opin Cardiol 26:245-55. 2011
    ..Herein, we summarize and integrate insights from studies which investigated how LVAD unloading influences the structure and function of the failing human heart...
  40. ncbi request reprint Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure
    Heidi T May
    LDS Hospital, Salt Lake City, Utah, USA
    Am J Cardiol 98:653-8. 2006
    ..In conclusion, elevated TC appears to be associated with improved survival. The effect was stronger in patients receiving statin therapy, but the cause of this differential effect is uncertain...
  41. doi request reprint Tuberculosis in a solid-organ transplant recipient: modern-day implications
    Ayad Jazrawi
    UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Heart Lung Transplant 28:191-3. 2009
    ..Herein we examine the role of the different tests used in diagnosis of TB and review the specifics of anti-mycobacterial therapy and the public health implications of TB in a SOT recipient...
  42. doi request reprint Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation
    Jose N Nativi
    U T A H Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Heart Lung Transplant 29:235-9. 2010
    ..As such, organs would be allocated to the sickest recipients with highest listing status across the region. Our aim was to determine the impact of the new policy on the procurement and transplant process within our program...
  43. doi request reprint Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database
    Melanie D Everitt
    Utah Transplant Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, Utah, USA
    J Heart Lung Transplant 28:1254-60. 2009
    ..ABO-I transplantation has resulted in reduced waitlist mortality in some countries. This study assessed the effect of an ABO-I listing strategy on pre-transplant outcomes in the United States...
  44. doi request reprint A novel non-invasive method to assess aortic valve opening in HeartMate II left ventricular assist device patients using a modified Karhunen-Loève transformation
    Corey J Bishop
    Utah Artificial Heart Program, Intermountain Medical Center, Murray, Utah 84157, USA
    J Heart Lung Transplant 29:27-31. 2010
    ....
  45. ncbi request reprint Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support
    Stavros G Drakos
    LDS Hospital, Salt Lake City, Utah 84143, USA
    Ann Thorac Surg 83:62-7. 2007
    ..Determining which pretransplantation (TX) characteristics predict the development of chronic renal dysfunction (CRD) or death after heart TX would enable more accurate risk assessment at the time of candidate evaluation...
  46. ncbi request reprint Percutaneous coronary interventions with stents in cardiac transplant recipients
    Feras M Bader
    Department of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 25:298-301. 2006
    ..The aim of this study was to review our experience with percutaneous coronary intervention (PCI) with stents in cardiac transplant recipients...
  47. ncbi request reprint Effect of mechanical circulatory support on outcomes after heart transplantation
    Stavros G Drakos
    Utah Transplantation Affiliate Hospitals Cardiac Transplant Program, Salt Lake City, UT, USA
    J Heart Lung Transplant 25:22-8. 2006
    ....
  48. doi request reprint Improving outcomes with long-term "destination" therapy using left ventricular assist devices
    James W Long
    Utah Artificial Heart Program, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Thorac Cardiovasc Surg 135:1353-60; discussion 1360-1. 2008
    ....
  49. doi request reprint Controversies in defining cardiac antibody-mediated rejection: need for updated criteria
    Abdallah G Kfoury
    Intermountain Medical Center and Intermountain Healthcare, Cardiac Transplant Program, Salt Lake City, Utah 84107, USA
    J Heart Lung Transplant 29:389-94. 2010
    ..This perspective examines some of the contentious and unresolved issues in cardiac AMR as the transplant community makes concrete steps towards updating its defining criteria...
  50. doi request reprint Noninvasive predictor of HeartMate XVE pump failure by neural network and waveform analysis
    Nathanael O Mason
    Utah Artificial Heart Program, Intermountain Medical Center part of Intermountain Healthcare, Murray, Utah, USA
    ASAIO J 56:1-5. 2010
    ..Waveforms (n = 454) were collected for 21 patients with failed pumps. An artificial neural network was used to predict pump failure within 30 days from the waveform characteristics identified though signal processing...
  51. doi request reprint End-of-life decision making and implementation in recipients of a destination left ventricular assist device
    Sally Brush
    Utah Artificial Heart Program, and Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah 84107, USA
    J Heart Lung Transplant 29:1337-41. 2010
    ..Nonetheless, end-of-life (EOL) issues are inevitable and how to approach them underreported...
  52. ncbi request reprint C-reactive protein predicts death in patients with non-ischemic cardiomyopathy
    Brianna S Ronnow
    Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
    Cardiology 104:196-201. 2005
    ..0) significantly and independently predicted mortality. Even in the absence of coronary artery disease, patients with left ventricular dysfunction are at increased risk of mortality based on their baseline CRP concentrations...
  53. ncbi request reprint Tricuspid valve replacement after cardiac transplantation
    Rami Alharethi
    Cardiology Division, University of Utah Health Sciences Center, Salt Lake City, USA
    J Heart Lung Transplant 25:48-52. 2006
    ..However, tricuspid valve replacement or repair (TVR) is rare. The aim of this study is to evaluate our experience with TVR in cardiac transplant recipients...
  54. ncbi request reprint Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial
    Michael X Pham
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    J Heart Lung Transplant 26:808-14. 2007
    ....
  55. ncbi request reprint Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, USA
    Circulation 116:497-505. 2007
    ..In the present study, we describe outcomes of DT in the post-REMATCH era in the United States...